Search Results

Indigo Percutaneous Mechanical Thrombectomy System

Experts discuss a potential paradigm shift in acute clot management in venous and arterial occlusions.

With Michael Lichtenberg, MD, FESC; Theodosios Bisdas, MD; Jos C. van den Berg, MD, PhD; Yann Le Bras, MD; Francois Petitpierre, MD; and Florian Wolf, MD, MBA, EBIR, EBCR

Indigo System for Thromboembolic Disease

With James F. Benenati, MD; Jos C. van den Berg, MD, PhD; Davide Fior, MD; Francesco Vacirca, MD; Rocco Corso, MD; Maurizio Cariati, MD; Umberto G. Rossi, MD, EBIR; Dr. med. Enrique Alejandre-Lafont; Arturo del Toro, MD; David Romero Alonso, MD; Simon T. Hilliard, FRCR; and Brendan C. Koo, FRCR

Tools for Dense and Durable Embolisations

With Frank R. Arko III, MD; Jos C. van den Berg, MD, PhD; Florian Wolf, MD, MBA, EBIR, EBCR; Alexander Aguinaga Alesanco, MD; Javier Izquierdo, MD; Homoyoon Mehrzad, MD; and Alexander Massmann, MD

The Indigo System and CAT8

Experts discuss the use of the Indigo System and CAT8 for thrombectomy and fistula salvage.

With Jos C. van den Berg, MD, PhD; Bella Huasen, MBChB, MRCS, DipEd, FRCR; Juan José Ciampi Dopazo, MD, EBIR; Pilar Servent Sáenz, MD; Maria Antonella Ruffino, MD, EBIR; Andrea Mancini, MD; Stefano Molinaro, MD; Andrea Discalzi, MD; Paolo Fonio, MD; Clément Marcelin, MD; Francois Petitpierre, MD; and Yann Le Bras, MD

How Self-Expanding Bare-Metal Stent Design Can Affect Procedural Results

Clinical outcomes in treatment of femoropopliteal artery disease with the Pulsar-18 stent.

By Jos C. van den Berg, MD, PhD, and Michael Lichtenberg, MD, FESC

Spur RST: Maximizing BTK CLTI Treatment Outcomes Without Compromising Safety

Physicians describe their experiences using the Spur Retrievable Scaffold followed by a DCB as a novel CLTI therapy that facilitates acute luminal gain, minimizes vessel recoil, and enhances drug delivery.

With Jos C. van den Berg, MD, PhD; Marcus Thieme, MD; Marianne Brodmann, MD; Leyla Schweiger, MD; and Thomas Zeller, MD

DCB Use in the Real World

A panel of experts discusses recommendations for optimizing outcomes when treating complex SFA and popliteal lesions with drug-coated balloon technology.

With Peter A. Schneider, MD; Prakash Krishnan, MD; Jos C. van den Berg, MD, PhD; Gunnar Tepe, MD; Lawrence A. Garcia, MD; and Krishna Rocha-Singh, MD

Indigo® System for Thromboembolic Disease

With Frank R. Arko III, MD; Scott L. Stevens, MD; James F. Benenati, MD; Christopher W. Boyes, MD; Paul Perkowski, MD; Laurel H. Hastings, MD; Mikel Sadek, MD; Chandrahas Patel, MD; and Jos C. van den Berg, MD, PhD

Perspectives on 2-Year Drug-Coated Balloon Data

A panel of experts discusses how the 2-year IN.PACT SFA and 1-year IN.PACT Global Study data affect decisions in real-world clinical practice.

With Marianne Brodmann, MD; John H. Rundback, MD, FAHA, FSVM, FSIR; Peter A. Schneider, MD; and Jos C. van den Berg, MD, PhD

Perspectives on 2-Year Drug-Coated Balloon Data

A panel of experts discusses how the 2-year IN.PACT SFA and 1-year IN.PACT Global Study data affect decisions in real-world clinical practice.

With Marianne Brodmann, MD; John H. Rundback, MD, FAHA, FSVM, FSIR; Peter A. Schneider, MD; and Jos C. van den Berg, MD, PhD